Get the Stockscreener App
279.29
2.69%
7.6326
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $279.29, with a volume of 1.92M.
It is up +2.69% in the last 24 hours and down -0.66% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$271.66
Open:
$273.7
24h Volume:
1.92M
Relative Volume:
0.64
Market Cap:
$150.21B
Revenue:
$34.13B
Net Income/Loss:
$5.93B
P/E Ratio:
25.48
EPS:
10.96
Net Cash Flow:
$10.92B
1W Performance:
+1.44%
1M Performance:
-0.66%
6M Performance:
-0.39%
1Y Performance:
-8.78%
1-Day Range:
$273.12
$279.63
1-Week Range:
$269.10
$279.63
52-Week Range:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
279.36 | 148.33B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
725.78 | 677.89B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
153.84 | 366.90B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
185.89 | 328.04B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
113.16 | 218.66B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
70.45 | 297.80B | 43.59B | 15.04B | 10.74B | 3.3766 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
B. Riley Wealth Advisors Inc. Decreases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Leigh Baldwin & CO. LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Shufro Rose & Co. LLC Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
95,000 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Polar Asset Management Partners Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Lowered by Gould Capital LLC - MarketBeat
Amgen shareholders approve executive pay, ratify accountants By Investing.com - Investing.com India
19,141 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Perennial Advisors LLC - MarketBeat
Aurdan Capital Management LLC Acquires New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mackenzie Financial Corp Sells 2,646 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Zacks Research Forecasts Amgen's Q2 Earnings (NASDAQ:AMGN) - MarketBeat
Waverly Advisors LLC Increases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Zurich Insurance Group Ltd FI Reduces Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Westwood Holdings Group Inc. Sells 3,064 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Rep. Marjorie Taylor Greene Buys Amgen Inc. (NASDAQ:AMGN) Stock - MarketBeat
Ball & Co Wealth Management Inc. Purchases Shares of 14,245 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sunbelt Securities Inc. Raises Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
GF Fund Management CO. LTD. Acquires Shares of 121,782 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Vise Technologies Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by GTS Securities LLC - MarketBeat
Forum Financial Management LP Boosts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Worldquant Millennium Advisors LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
FY2025 Earnings Forecast for Amgen Issued By Zacks Research - MarketBeat
Parr Mcknight Wealth Management Group LLC Takes $3.75 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Public Employees Retirement System of Ohio Buys New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Novem Group Acquires New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
4,827 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Pacific Point Advisors LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Western Wealth Management LLC - MarketBeat
JT Stratford LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Tidal Investments LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Valueworks LLC Sells 1,922 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Two Sigma Investments LP Acquires 543,545 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Toronto Dominion Bank Has $21.35 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
USS Investment Management Ltd Cuts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
With 81% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns - Yahoo Finance
Blue Fin Capital Inc. Buys 1,431 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now - The Motley Fool
Focus Partners Advisor Solutions LLC Purchases 2,264 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Raised by Twinbeech Capital LP - MarketBeat
Vivaldi Capital Management LP Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stake Decreased by Lazard Asset Management LLC - MarketBeat
Siemens Fonds Invest GmbH Sells 22,764 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s Enbrel Targeted as Colorado Panel Works on Payment Cap - Bloomberg Law News
Wall Street Zen Upgrades Amgen (NASDAQ:AMGN) to Strong-Buy - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Two Sigma Advisers LP - MarketBeat
Nephrology Drugs Market in 2025 Detailed Study Analysis | Amgen Inc., F. Hoffmann-La Roche Ltd, Sanofi, Novartis AG - openPR.com
The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen - Yahoo Finance
35,409 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Ames National Corp - MarketBeat
Tema Etfs LLC Takes $2.91 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Silvercrest Asset Management Group LLC - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):